日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The biomarker potential of circPOLD1 and its binding protein YBX1 in cervical carcinogenesis.

circPOLD1及其结合蛋白YBX1在宫颈癌发生中的生物标志物潜力

Zhao Lu, Chen Xin, Zhang Yanan, Cen Yixuan, Zhu Tingjia, Wang Lingfang, Xia Lili, Li Yang, Cheng Xiaodong, Xie Xing, Lu Weiguo, Xu Junfen

PARP1-stabilised FOXQ1 promotes ovarian cancer progression by activating the LAMB3/WNT/β-catenin signalling pathway

PARP1 稳定的 FOXQ1 通过激活 LAMB3/WNT/β-catenin 信号通路促进卵巢癌进展

Jiangchun Wu #, Yong Wu #, Siyu Chen #, Qinhao Guo, Yang Shao, Chaohua Liu, Kailin Lin, Simin Wang, Jun Zhu, Xiaojun Chen, Xingzhu Ju, Lingfang Xia, Xiaohua Wu

Programmed death ligand-1 regulates angiogenesis and metastasis by participating in the c-JUN/VEGFR2 signaling axis in ovarian cancer

程序性死亡配体-1通过参与卵巢癌的c-JUN/VEGFR2信号轴调控血管生成和转移

Yufei Yang, Lingfang Xia, Yong Wu, Hongyu Zhou, Xin Chen, Haoran Li, Midie Xu, Zihao Qi, Ziliang Wang, Huizhen Sun, Xi Cheng

Identification of Chemoresistance-Associated Key Genes and Pathways in High-Grade Serous Ovarian Cancer by Bioinformatics Analyses

通过生物信息学分析鉴定高级别浆液性卵巢癌化学耐药相关关键基因和通路

Yong Wu #, Lingfang Xia #, Qinhao Guo #, Jun Zhu, Yu Deng, Xiaohua Wu

Immune profiling reveals prognostic genes in high-grade serous ovarian cancer

免疫分析揭示高级别浆液性卵巢癌的预后基因

Yong Wu, Lingfang Xia, Ping Zhao, Yu Deng, Qinhao Guo, Jun Zhu, Xiaojun Chen, Xingzhu Ju, Xiaohua Wu

Luteinizing hormone compromises the in vivo anti-tumor effect of cisplatin on human epithelial ovarian cancer cells

黄体生成素影响顺铂对人上皮性卵巢癌细胞的体内抗肿瘤作用

Yan Huang, Yuqi Zhou, Lingfang Xia, Jia Tang, Hao Wen, Meiqin Zhang

Luteinizing hormone inhibits cisplatin-induced apoptosis in human epithelial ovarian cancer cells

黄体生成素抑制顺铂诱导的人类上皮性卵巢癌细胞凋亡

Lingfang Xia, Hao Wen, Xiaotian Han, Jia Tang, Yan Huang